The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Official Title: Observational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay
Study ID: NCT02376296
Brief Summary: In this observational study, blood samples for pharmacokinetic (PK) testing will be collected from subjects with metastatic prostate cancer during their treatment with docetaxel. Plasma levels of docetaxel will be determined, and the subjects docetaxel exposure levels, determined as an area under the curve (AUC), will be retrospectively correlated with reports of toxicity, tumor response, quality of life, time to disease progression and overall survival to provide guidance on what the appropriate target range for docetaxel exposure should be for metastatic prostate cancer subjects receiving docetaxel therapy for their disease.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
UPMC CancerCenter - Beaver, Beaver, Pennsylvania, United States
UPMC CancerCenter - Upper St. Clair, Bethel Park, Pennsylvania, United States
UPMC CancerCenter - Horizon, Farrell, Pennsylvania, United States
Arnold Palmer Cancer Center - Oakbrook, Greensburg, Pennsylvania, United States
Arnold Palmer Cancer Center, Greensburg, Pennsylvania, United States
UPMC CancerCenter - Greenville, Greenville, Pennsylvania, United States
UPMC CancerCenter - Indiana, Indiana, Pennsylvania, United States
UPMC CancerCenter at John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States
UPMC CancerCenter - Mckeesport, McKeesport, Pennsylvania, United States
UPMC CancerCenter - Monroeville, Monroeville, Pennsylvania, United States
Arnold Palmer Medical Oncology - Mount Pleasant, Mount Pleasant, Pennsylvania, United States
UPMC CancerCenter - New Castle, New Castle, Pennsylvania, United States
UPMC CancerCenter - St. Margaret, Pittsburgh, Pennsylvania, United States
UPMC CancerCenter - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
UPMC CancerCenter - Passavant HOA, Pittsburgh, Pennsylvania, United States
UPMC CancerCenter - Passavant OHA, Pittsburgh, Pennsylvania, United States
UPMC CancerCenter - Northwest, Seneca, Pennsylvania, United States
UPMC CancerCenter - Uniontown, Uniontown, Pennsylvania, United States
UPMC CancerCenter - Washington, Washington, Pennsylvania, United States
UPMC CancerCenter - Jefferson, West Mifflin, Pennsylvania, United States
Name: Rahul A Parikh, MD, PhD
Affiliation: UPMC CancerCenter
Role: PRINCIPAL_INVESTIGATOR